- June
- 19
Prepackaged Nestle Toll House refrigerated cookie dough is the latest food on the dangerous list. Since March, 66 people in 28 states have gotten sick with E. coli poisoning after eating the food, according to the Food and Drug Administration.
Nestle USA, which manufactures and markets the Toll House cookie dough, has recalled the product. Check the Nestle website for a list of products that might be contaminated.
E. coli O157:H7 causes abdominal cramping, vomiting and a diarrheal illness, often with bloody stools. Most healthy adults can recover completely within a week. Young children and the elderly are at highest risk for developing HUS, which can lead to serious kidney damage and even death.
So far, 25 people who have gotten sick from eating the cookie dough have been hospitalized, 7 with a severe complication called Hemolytic Uremic Syndrome. No one has died
Posted by Jane Lerner on Friday, June 19th, 2009 at 2:29 pm |
Print This Post
|
Email This Post
| 1 Comment »
- June
- 16
A popular cold remedy could cause permanent loss of smell, the U.S. Food and Drug Administration is warning. The FDA is advising consumers to stop using three Zicam products marketed over-the-counter as cold remedies because they can cause long-lasting or permanent loss of smell.
The products are:
• Zicam Cold Remedy Nasal Gel
• Zicam Cold Remedy Nasal Swabs
• Zicam Cold Remedy Swabs, Kids Size (a discontinued product)
The FDA has received more than 130 reports of loss of sense of smell associated with the use of these three Zicam products. In these reports, many people who experienced a loss of smell said the condition occurred with the first dose; others reported a loss of the sense of smell after multiple uses of the products.
People who have experienced a loss of sense of smell or other problems after use of the affected Zicam products should contact their health care professional. The loss of sense of smell can adversely affect a person’s quality of life, and can limit the ability to detect the smell of gas or smoke or other signs of danger in the environment.
The FDA has issued Matrixx Initiatives, maker of these Zicam products, a warning letter telling it that these products cannot be marketed without FDA approval.
Health care professionals and consumers are encouraged to report adverse events (side effects) that may be related to the use of these products to the FDA’s MedWatch Adverse Event Reporting program online, by regular mail, fax or phone.—Online—Regular Mail: use FDA postage paid form 3500 and mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787—Fax: 800-FDA-0178—Phone: 800-FDA-1088
For more information:
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm166834.htm
Posted by Jane Lerner on Tuesday, June 16th, 2009 at 2:34 pm |
Print This Post
|
Email This Post
| 1 Comment »
- June
- 11
The World Health Organization told its member nations it was declaring a swine flu pandemic Thursday — the first global flu epidemic in 41 years — as infections climbed in the United States, Europe, Australia, South America and elsewhere.
In a statement sent to member countries, WHO said it decided to raise the pandemic warning level from phase 5 to 6 — its highest alert — after holding an emergency meeting on swine flu with its experts.
The long-awaited pandemic decision is scientific confirmation that a new flu virus has emerged and is quickly circling the globe. It will trigger drugmakers to speed up production of a swine flu vaccine and prompt governments to devote more money toward efforts to contain the virus, the Associated Press reports.
There have been 1,241 confirmed cases of the flu in New York, with 46 in Westchester, 8 in Rockland and 2 in Putnam, according to the state Department of Health.
The total number of people with the illness, which is generally mild, is probably much higher, health officials said. Most people who are sick with the flu are not specifically tested for swine flu.
Posted by Jane Lerner on Thursday, June 11th, 2009 at 11:25 am |
Print This Post
|
Email This Post
| Post a Comment »